Researchers have developed an anti-malaria vaccine that uses blood-stage malaria parasites that were modified with a chemical agent to prevent replication. Mice injected with the vaccine showed immunity to a variety of malaria species for more than 100 days, according to the study published in the Journal of Clinical Investigation.

Full Story:

Related Summaries